BACKGROUND: Diabetic retinopathy is associated with accumulation of advanced glycation end products in the retinal microvasculature. LR-90 is an effective multistage inhibitor of advanced glycation with renoprotective and anti-inflammatory properties. AIM: To explore the role of LR-90 in the progression of experimental diabetic retinopathy. METHODS: Streptozotocin-induced diabetic Sprague-Dawley rats were treated with LR-90 (50 mg/l in drinking water) for up to 32 weeks. At the end of the study, eyes were enucleated and subjected to trypsin digestion and staining with light green/haematoxylin. Acellular capillaries and pericytes were quantified in random fields using light microscopy. RESULTS: In the LR-90-treated diabetic animals, acellular capillary numbers were reduced to 1.63 (0.20) from 2.58 (0.49) (p<0.05) in diabetic controls. LR-90 treatment also restored the pericyte deficit from 18.12 (0.98) in diabetic rats to 24.19 (0.76) (p<0.001). CONCLUSION: These findings show that LR-90 can effectively inhibit important lesions of diabetic retinopathy. This agent has potential for preventing retinopathy in patients with diabetes.
BACKGROUND:Diabetic retinopathy is associated with accumulation of advanced glycation end products in the retinal microvasculature. LR-90 is an effective multistage inhibitor of advanced glycation with renoprotective and anti-inflammatory properties. AIM: To explore the role of LR-90 in the progression of experimental diabetic retinopathy. METHODS:Streptozotocin-induced diabeticSprague-Dawley rats were treated with LR-90 (50 mg/l in drinking water) for up to 32 weeks. At the end of the study, eyes were enucleated and subjected to trypsin digestion and staining with light green/haematoxylin. Acellular capillaries and pericytes were quantified in random fields using light microscopy. RESULTS: In the LR-90-treated diabetic animals, acellular capillary numbers were reduced to 1.63 (0.20) from 2.58 (0.49) (p<0.05) in diabetic controls. LR-90 treatment also restored the pericyte deficit from 18.12 (0.98) in diabeticrats to 24.19 (0.76) (p<0.001). CONCLUSION: These findings show that LR-90 can effectively inhibit important lesions of diabetic retinopathy. This agent has potential for preventing retinopathy in patients with diabetes.
Authors: Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier Journal: J Am Soc Nephrol Date: 2015-08-26 Impact factor: 10.121
Authors: Cristiano P Vieira; Seth D Fortmann; Masroor Hossain; Ana Leda Longhini; Sandra S Hammer; Bright Asare-Bediako; David K Crossman; Micheli S Sielski; Yvonne Adu-Agyeiwaah; Mariana Dupont; Jason L Floyd; Sergio Li Calzi; Todd Lydic; Robert S Welner; Gary J Blanchard; Julia V Busik; Maria B Grant Journal: JCI Insight Date: 2020-07-09
Authors: T M Curtis; R Hamilton; P-H Yong; C M McVicar; A Berner; R Pringle; K Uchida; R Nagai; S Brockbank; A W Stitt Journal: Diabetologia Date: 2010-11-30 Impact factor: 10.122
Authors: Ashay D Bhatwadekar; Eleni Beli; Yanpeng Diao; Jonathan Chen; Qianyi Luo; Alpha Alex; Sergio Caballero; James M Dominguez; Tatiana E Salazar; Julia V Busik; Mark S Segal; Maria B Grant Journal: Am J Pathol Date: 2017-04-19 Impact factor: 4.307
Authors: Eleni Beli; James M Dominguez; Ping Hu; Jeffrey S Thinschmidt; Sergio Caballero; Sergio Li Calzi; Defang Luo; Sumathi Shanmugam; Tatiana E Salazar; Yaqian Duan; Michael E Boulton; Susanna Mohr; Steven F Abcouwer; Daniel R Saban; Jeffrey K Harrison; Maria B Grant Journal: J Mol Med (Berl) Date: 2016-06-25 Impact factor: 4.599